Divya Srivastava is a visiting fellow at LSE Health and works as a health economist at the Organisation for Economic Cooperation and Development (OECD) in Paris. She is involved in projects relating to value for money which include investigating medical practice variations and payment systems across OECD countries. She is also an associate editor of the journal Globalization and Health, an open access online journal addressing key issues in global health and the influences of globalization upon health. www.globalizationandhealth.com
Divya holds B.Sc in Statistics from the University of Manitoba (Canada), a M.A. in Economics from McMaster University (Canada), MSc. in International Health Policy from the LSE and a PhD from the LSE. Research interests include comparative health policy, health economics and pharmaceutical policy.
Srivastava, D., and McGuire, A. (2013) "Analysis of prices paid by low-income countries - how price sensitive is government demand for medicines?" LSE Health working paper. 10/2013. LSE Health, London School of Economics and Political Science, London, UK.
Corallo AN, Croxford R, Srivastava D, Goodman DC, Stukel TA (2013) "A systematic review of medical practice variations in OECD countries", Health Policy (in press).
Mladovsky,P., Srivastava,D., Cylus,J, Marina Karanikolos, Tamás Evetovits, Sarah Thomson,Martin McKee. (2012). Health policy responses to the financial crisis in Europe. Policy Summary 5,World Health Organization, on behalf of the European Observatory on Health Systems and Policies, Copenhagen: WHO European Regional Office.
Srivastava D, Mladovsky P (2011). Health policy at a time of economic crisis. Research note produced for the EC as part of the Health and Living Conditions, Network of the European Observatory on the Social Situation and Demography.
Srivastava, D. (2009), Policy Discussion Paper on Advanced Market Commitments and Patent Pools, A report commissioned by AusAID, London: Australian Agency for International Development.
Srivastava, D. (2008), A country level report on the pharmaceutical sector in India Part One: Institutions involved in pharmaceutical regulation, A study commissioned by DFID, London: Department For International Development.
Srivastava, D. (2008). Is prevention better than cure? A review of the evidence, Research Note for the European Commission, DG Employment and Social Affairs.
Le Grand J and Srivastava D (2008). Incentives for Prevention, Health England Report No. 3., London: Health England.
Wismar, M., McKee, M., Ernst, K., Srivastava, D., Busse, R. (2008). Health targets in Europe Learning from experience, Copenhagen: WHO Regional Office for Europe on behalf of the European Observatory on Health Systems and Policies.
Mossialas EM and Srivastava D (2008). Pharmaceutical policies in Finland: challenges and opportunities, Copenhagen: WHO Regional Office for Europe on behalf of the European Observatory on Health Systems and Policies; Ministry of Social Affairs and Health, Finland.
Figueras J, Lessof S, and Srivastava D. (2006). (Chapter 17) ‘Managing Paradox’, In: Constructive Conversations about Health: Policy and Values. Marinker Marshall (Editor), Oxford: Radcliffe Publishing Ltd.
Wismar M, Ernst K, Srivastava D, Busse R. (2006). ‘Health targets and (good) governance,’ Euro Observer, Vol. 8, No 1, p. 1-5.